scispace - formally typeset
V

Vahid Eslami

Researcher at Shahid Beheshti University of Medical Sciences and Health Services

Publications -  22
Citations -  663

Vahid Eslami is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Myocardial infarction & Fractional flow reserve. The author has an hindex of 8, co-authored 22 publications receiving 265 citations.

Papers
More filters
Journal ArticleDOI

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.

Inspiration Investigators, +63 more
- 27 Apr 2021 - 
TL;DR: In this paper, the authors evaluated the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
Journal ArticleDOI

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.

Behnood Bikdeli, +64 more
TL;DR: In this article, the authors report the final (90-day) results of the Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial (INSPIRATION) study.
Journal Article

Evaluation of QT, QT dispersion, and T-wave peak to end time changes after primary percutaneous coronary intervention in patients presenting with acute ST-elevation myocardial infarction.

TL;DR: The findings suggest that ischemia-induced QTd and TPE are important arrhythmogenic parameters responding to successful primary PCI and may be used as markers for successful repercussion.
Journal ArticleDOI

The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19.

TL;DR: CT-measured cardiac indices might have predictive value regarding survival and extent of lung involvement in hospitalized patients with COVID-19 and could possibly be used for the risk stratification of these patients and for guiding therapy decision-making.
Journal ArticleDOI

Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship?

TL;DR: Routine laboratory tests that represent status of inflammation can be used as cost-effective prognostic markers of COVID-19 and a significant association between EAT volume and other inflammatory biomarkers might explain the more severe disease in obese patients.